The present proceedings represent ideas and recommendations for conducting
investigations of Controlled/Modified Release Products subjected to:
Definitions, Pharmaceutical Characerization, In Vivo/In Vitro Association,
Biopharmaceutical Characterization, e.g. Study Design, Main Variables,
Single/Multiple Dosing Statistical Evaluation and Decision Criteria and
Clinical Characterization of New and Known Drug Substances.
Henning Blume